The recent annual meeting of the Consortium of Multiple Sclerosis Centers (CMSC) brought researchers and healthcare professionals to New [...]
A common acne medicine called minocycline can reduce the rate of multiple sclerosis progression in patients who are at early stages of [...]
Most people who care for multiple sclerosis (MS) patients are happy to be caregivers, but they admit that their own emotional and physical [...]
WHIPPANY, N.J., May 30, 2017 – Bayer today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental [...]
Multiple sclerosis patients who benefited from Ocrevus (ocrelizumab) in two Phase 3 clinical trials continued to benefit when they [...]
Young multiple sclerosis (MS) patients who engage in physical activity can relieve symptoms of depression, concludes a Canadian study [...]
Cladribine tablets reduced relapsing multiple sclerosis patients’ annual relapse rate by 55 to 57 percent, depending on the dose, [...]
